Adrian Gottschalk
2023
In 2023, Adrian Gottschalk earned a total compensation of $2.5M as President and Chief Executive Officer at Foghorn Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,650 |
|---|---|
| Option Awards | $1,719,292 |
| Salary | $579,000 |
| Other | $3,000 |
| Total | $2,503,942 |
Gottschalk received $1.7M in option awards, accounting for 69% of the total pay in 2023.
Gottschalk also received $202.7K in non-equity incentive plan, $579K in salary and $3K in other compensation.
Rankings
In 2023, Adrian Gottschalk's compensation ranked 378th out of 2,647 executives tracked by ExecPay. In other words, Gottschalk earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 378 out of 2,647 | 86th |
Division Manufacturing | 217 out of 1,447 | 85th |
Major group Chemicals And Allied Products | 153 out of 817 | 81st |
Industry group Drugs | 150 out of 783 | 81st |
Industry Pharmaceutical Preparations | 91 out of 555 | 84th |
Source: SEC filing on May 3, 2024.
Gottschalk's colleagues
We found two more compensation records of executives who worked with Adrian Gottschalk at Foghorn Therapeutics in 2023.